As published in Fertility and Sterility Vol. 65, No. 6, pp. 1119-1124

RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium


Elizabeth A. Stewart, M.D., Douglas J. Austin, M.D., Prachee Jain, B.A., Martha D. Penglase, A.B., Romana A. Nowak, Ph.D.
From the Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts

Objective: To assess the action of RU486 (mifepristone), in the presence and absence of P, on PRL production by explant cultures of leiomyoma and myometrium.
Design: Explant cultures using tissue from nine premenopausal women undergoing hysterectomy in the proliferative phase of the menstrual cycle; immunohistochemical staining of tissue sections from five patients for P receptor (PR) subtype.
Main Outcome Measures: Prolactin secretion (measured by RIA), lactate dehydrogenase secretion (measured by quantitative colorimetric assay), and immunohistochemistry for PR subtype.
Results: Prolactin secretion was decreased in leiomyomas by RU486 at concentrations of 10-7 M and 10-5 M when normal serum-containing medium was used. In experiments with all detectable P removed from serum, PRL secretion was suppressed in both leiomyomas and myometrium at an RU486 concentration of 10-7 M. Immunohistochemistry results suggest that the A form of the PR is the dominant form in both leiomyomas and myometrium.
Conclusions: Prolactin production is suppressed in both leiomyomas and myometrium after treatment with RU486 in vitro, and this suppression may serve as a marker for the clinical effectiveness of agents used in the treatment of leiomyomas.


Figure 1.

















Figure 2.
















Figure 3.










Immunohistochemical staining of leiomyomas (A to C) and normal myometrium (D to F) for PR subtypes (magnification in all cases X178). Sections were incubated with the following primary antibodies: (A and D) 10 mg/mL of nonspecific mouse IgG as a negative control; (B and E) 10 mg/mL of AB-52, which recognizes both A and B isoforms; (C and F) 50 microgram/mL of B-30, which recognizes the B isoform. Staining with B-30 yielded similar results at concentrations of 10 and 20 microgram/mL. Immunostaining of samples from four additional patients were similar. These photographs demonstrate that staining for PR is greater in leiomyomas than in myometrium (B versus E). Both nuclear staining (curved arrow) and cytoplasmic staining (straight arrow) are increased in leiomyomas (B). In addition, for both leiomyomas and myometrium, there is little specific staining for the B isoform (C versus B) and (F versus E). In F, the arrow indicates a cell with no staining except for hematoxylin counterstaining of the nucleus.